SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.31+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tharos who wrote (6567)6/24/1998 12:36:00 AM
From: aknahow  Read Replies (3) of 17367
 
This is probably a classic example of how a company fails to involve or follow the p.r. depts. advice. If XOMA had simply said we intend to do this trial and the F.D.A. has approved the design, (shared at least some of the details), and the purpose of the trial as well as the implications, I think we would have been better served. XOMA reads these post but so far they have not really answered the most basic questions.

Before the presentation by Falk I asked that shareholders be kept informed asap. Seemed like a great opportunity for XOMA to provide information on what is a very important trial. If the information is confidential then no presentation should have been made. This issue will not go away until XOMA provides more information. How about a vote on the thread? Is this issue being blown out of proportion?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext